in

May / June 2020

In this issue
  • in

    MOTIVIDEOS

    Normally, this section is devoted to helping you kick off a morning meeting with something educational, inspirational, entertaining, or all three. You may have noticed that things have changed, so here are some videos that might be helpful during this more challenging time when keeping in touch is a little trickier and technologically challenging. WORK […] More

    Read More

  • in

    Zimmer Biomet VP on Covering the Territory

    The mission at Zimmer Biomet is about mobility – restoring the capability to use your bones, joints and supportive tissues. That covers a lot of territory. But Brad Thomas covers even more. He sees his job as making sure the company’s skills are in place to assist customers and patients in every way possible. Brad […] More

    Read More

  • in

    Metrics on Covid-19: Highlights of the Evaluate Vantage Report

    We can always depend on Evaluate Vantage to keep us current on developments across the industry. Here are highlights from their most recent report, a compendium of articles on all aspects of how the coronavirus is impacting healthcare, and by extension all of us who depend on the professionals fighting this disease. The coronavirus pandemic […] More

    Read More

  • in

    Why I Work In Healthcare

    PEOPLE ON THE FRONTLINES EDITION Normally this section features people from across healthcare giving their reasons for working in the most essential industry in the country. But now we’d like to sharpen the focus to the people on the front lines who are truly heroic. Putting themselves at risk regularly, they work long hours to […] More

    Read More

  • in

    Gilead Sciences Secures Exclusive Option to Acquire Tizona Therapeutics for $300 Million

    FOSTER CITY, CA & SOUTH SAN FRANCISCO, CA, July 21, 2020 (Pitchbook) — Gilead Sciences, Inc. (Nasdaq: GILD) today announced that it will invest $300 million to acquire a 49.9 percent equity interest in Tizona Therapeutics, Inc., a privately held company developing first-in-class cancer immunotherapies. Gilead will also receive an exclusive option to acquire the remainder of […] More

    Read More

  • in

    MANAGING THROUGH THE PANDEMIC

    Bayer, Biogen, Sunovion, Astrazeneca and Other Execs on the Changes Driven by COVID-19 Recently, eyeforpharma held its spring Philadelphia event virtually. It was a comprehensive view of how the industry is addressing the pandemic, and we are running portions of it here as our roundtable article. The presenters offered hope, inspiration and a vision of […] More

    Read More

  • in

    TOP 50 BIOTECH COMPANIES

    As is evidenced by much of the commentary in this issue, as well as in the news today, biotech is more front and center than it ever was, given the challenges of containing Covid-19. It’s not just that disease itself that must be faced, but the many other conditions that put patients at greater risk […] More

    Read More

  • in

    Building Talent in the Covid-19 World

    ByCari Kraft, Jacobs Management Group INTRODUCTION Covid-19 has created challenges everywhere, including the hiring process. Research conducted in late March by Willis Towers Watson, a global risk management and advisory firm, shows that 42% of surveyed organizations have frozen or reduced hiring. But that means that 58% are still hiring. And, for those of us […] More

    Read More

  • in

    INDUSTRY TRENDS: BY THE NUMBERS

    Compiled by Cari Kraft, Jacobs Management Group, Inc. 450,548,197 Covid-19 tests worldwide As of April 30, 2020, over 450 million Covid-19 tests had been conducted around the world, yet countries continue to ramp up their testing capabilities and assess which tests are most accurate. Source: Our World In Data, Total COVID 19 tests, April 2020 291 […] More

    Read More

What do you think?

Written by hsandm

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

Loading…

0

Innovation When We Need it More Than Ever

MANAGING THROUGH THE PANDEMIC